Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Management of High Ferritin (Hyperferritinemia)

Diagnostic Approach

  • The European Association for the Study of the Liver recommends determining if hyperferritinemia is due to iron overload or other causes through transferrin saturation measurement, with a strength of evidence level of high 2
  • The American Gastroenterological Association suggests evaluating for hereditary hemochromatosis (HFE) through genetic testing if transferrin saturation is elevated, with a moderate level of evidence 1, 3
  • The American Association for the Study of Liver Diseases recommends assessing for end-organ damage through liver function tests and considering liver biopsy if cirrhosis is suspected, with a high level of evidence 4, 2

Treatment Protocol for Iron Overload

  • The American College of Gastroenterology recommends initiating weekly therapeutic phlebotomy (removal of 400-500 mL of blood) as tolerated, with a high level of evidence 2
  • The European Association for the Study of the Liver suggests monitoring hemoglobin and hematocrit before each phlebotomy session, with a moderate level of evidence 1, 3
  • The American Gastroenterological Association recommends postponing phlebotomy if anemia develops until resolved, with a high level of evidence 1, 3
  • The American Association for the Study of Liver Diseases suggests checking serum ferritin every 10-12 phlebotomies initially, more frequently as levels approach normal range, with a moderate level of evidence 1, 3
  • The European Association for the Study of the Liver recommends continuing therapeutic phlebotomy until ferritin reaches target of less than 50 μg/L, with a high level of evidence 1, 3

Maintenance Therapy

  • The American College of Gastroenterology recommends continuing maintenance phlebotomies every 3-6 months after achieving target ferritin, with a high level of evidence 1, 3
  • The European Association for the Study of the Liver suggests maintaining serum ferritin between 50-100 μg/L, with a moderate level of evidence 1, 3, 2
  • The American Gastroenterological Association recommends an alternative approach of ceasing phlebotomy and monitoring ferritin, restarting when ferritin reaches upper limit of normal, with a low level of evidence 1, 3

Special Considerations

  • The American Association for the Study of Liver Diseases recommends avoiding iron supplements and iron-fortified foods, with a high level of evidence 1, 3, 2
  • The European Association for the Study of the Liver suggests limiting vitamin C supplements to 500 mg/day, with a moderate level of evidence 1, 3
  • The American College of Gastroenterology recommends avoiding excess alcohol consumption, which can worsen liver damage, with a high level of evidence 1
  • The American Gastroenterological Association suggests maintaining a broadly healthy diet rather than strict iron restriction, with a low level of evidence 1, 3

Monitoring

  • The American Association for the Study of Liver Diseases recommends monitoring serum ferritin monthly during initial therapy and every 3-6 months during maintenance, with a high level of evidence 1, 3, 2
  • The European Association for the Study of the Liver suggests performing regular screening for hepatocellular carcinoma in patients with cirrhosis, with a moderate level of evidence 4
  • The American College of Gastroenterology recommends tailoring treatment approach to the underlying cause in patients with secondary iron overload, with a low level of evidence 4
  • The American Gastroenterological Association suggests that early treatment before development of cirrhosis and diabetes improves survival to normal population levels, with a high level of evidence 1, 3

Pitfalls and Caveats

  • The European Association for the Study of the Liver recommends avoiding overchelation by careful monitoring of ferritin levels, with a moderate level of evidence 2
  • The American Association for the Study of Liver Diseases suggests that patients with cirrhosis and iron overload should avoid raw shellfish due to risk of Vibrio vulnificus infection, with a high level of evidence 2

REFERENCES